Available on Spotify and Apple Podcasts

Episode 5: An interview with Kollet Barkhouse and James Romano

Here in the United States, health insurance is supposed to protect patients from the financial burden of expensive medical treatments. But all too often, it falls short—especially for those with hemophilia who rely on costly prescription medications.

Now, a new trend is making things even harder. Third-party vendors are pushing what's called 'alternative funding programs,' and they're specifically targeting high-cost specialty drugs.

If these programs continue to spread unchecked, they could cause real harm—leaving patients even more vulnerable, straining the health care system, and further complicating an already broken drug pricing market. It's a serious issue that needs attention.

🌟 Episode Overview: In this episode of Boundless B, Kollet Barkhouse and James Romano discuss how alternative funding programs affect those with hemophilia.

More about alternative funding programs

Made in partnership with Balancing Life’s Issues

Sponsored by Medexus.